Amphiregulin is a critical downstream effector of estrogen signaling in ERα-positive breast cancer

Esther A. Peterson, Edmund C. Jenkins, Kristopher A. Lofgren, Natasha Chandiramani, Hui Liu, Evelyn Aranda, Maryia Barnett, Paraic A. Kenny

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Estrogen stimulation promotes epithelial cell proliferation in estrogen receptor (ERα)-positive breast cancer. Many ERα target genes have been enumerated, but the identities of the key effectors mediating the estrogen signal remain obscure. During mouse mammary gland development, the estrogen growth factor receptor (EGFR) ligand amphiregulin acts as an important stage-specific effector of estrogen signaling. In this study, we investigated the role of amphiregulin in breast cancer cell proliferation using human tissue samples and tumor xenografts in mice. Amphiregulin was enriched in ERα-positivehumanbreast tumor cells and required for estrogen-dependent growth of MCF7 tumor xenografts. Furthermore, amphiregulin levels were suppressed in patients treated with endocrine therapy. Suppression of EGF receptor signaling appeared necessary for the therapeutic response in this setting. Our findings implicate amphiregulin as a critical mediator of the estrogen response in ERα-positive breast cancer, emphasizing the importance of EGF receptor signaling in breast tumor pathogenesis and therapeutic response.

Original languageEnglish (US)
Pages (from-to)4830-4838
Number of pages9
JournalCancer Research
Volume75
Issue number22
DOIs
StatePublished - Nov 15 2015

Fingerprint

Estrogen Receptors
Estrogens
Breast Neoplasms
Epidermal Growth Factor Receptor
Heterografts
Cell Proliferation
Neoplasms
Growth Factor Receptors
Human Mammary Glands
Amphiregulin
Therapeutics
Epithelial Cells
Ligands
Growth
Genes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Peterson, E. A., Jenkins, E. C., Lofgren, K. A., Chandiramani, N., Liu, H., Aranda, E., ... Kenny, P. A. (2015). Amphiregulin is a critical downstream effector of estrogen signaling in ERα-positive breast cancer. Cancer Research, 75(22), 4830-4838. https://doi.org/10.1158/0008-5472.CAN-15-0709

Amphiregulin is a critical downstream effector of estrogen signaling in ERα-positive breast cancer. / Peterson, Esther A.; Jenkins, Edmund C.; Lofgren, Kristopher A.; Chandiramani, Natasha; Liu, Hui; Aranda, Evelyn; Barnett, Maryia; Kenny, Paraic A.

In: Cancer Research, Vol. 75, No. 22, 15.11.2015, p. 4830-4838.

Research output: Contribution to journalArticle

Peterson, EA, Jenkins, EC, Lofgren, KA, Chandiramani, N, Liu, H, Aranda, E, Barnett, M & Kenny, PA 2015, 'Amphiregulin is a critical downstream effector of estrogen signaling in ERα-positive breast cancer', Cancer Research, vol. 75, no. 22, pp. 4830-4838. https://doi.org/10.1158/0008-5472.CAN-15-0709
Peterson EA, Jenkins EC, Lofgren KA, Chandiramani N, Liu H, Aranda E et al. Amphiregulin is a critical downstream effector of estrogen signaling in ERα-positive breast cancer. Cancer Research. 2015 Nov 15;75(22):4830-4838. https://doi.org/10.1158/0008-5472.CAN-15-0709
Peterson, Esther A. ; Jenkins, Edmund C. ; Lofgren, Kristopher A. ; Chandiramani, Natasha ; Liu, Hui ; Aranda, Evelyn ; Barnett, Maryia ; Kenny, Paraic A. / Amphiregulin is a critical downstream effector of estrogen signaling in ERα-positive breast cancer. In: Cancer Research. 2015 ; Vol. 75, No. 22. pp. 4830-4838.
@article{c29cb9c9e5a2481cb5345fc340ee0000,
title = "Amphiregulin is a critical downstream effector of estrogen signaling in ERα-positive breast cancer",
abstract = "Estrogen stimulation promotes epithelial cell proliferation in estrogen receptor (ERα)-positive breast cancer. Many ERα target genes have been enumerated, but the identities of the key effectors mediating the estrogen signal remain obscure. During mouse mammary gland development, the estrogen growth factor receptor (EGFR) ligand amphiregulin acts as an important stage-specific effector of estrogen signaling. In this study, we investigated the role of amphiregulin in breast cancer cell proliferation using human tissue samples and tumor xenografts in mice. Amphiregulin was enriched in ERα-positivehumanbreast tumor cells and required for estrogen-dependent growth of MCF7 tumor xenografts. Furthermore, amphiregulin levels were suppressed in patients treated with endocrine therapy. Suppression of EGF receptor signaling appeared necessary for the therapeutic response in this setting. Our findings implicate amphiregulin as a critical mediator of the estrogen response in ERα-positive breast cancer, emphasizing the importance of EGF receptor signaling in breast tumor pathogenesis and therapeutic response.",
author = "Peterson, {Esther A.} and Jenkins, {Edmund C.} and Lofgren, {Kristopher A.} and Natasha Chandiramani and Hui Liu and Evelyn Aranda and Maryia Barnett and Kenny, {Paraic A.}",
year = "2015",
month = "11",
day = "15",
doi = "10.1158/0008-5472.CAN-15-0709",
language = "English (US)",
volume = "75",
pages = "4830--4838",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "22",

}

TY - JOUR

T1 - Amphiregulin is a critical downstream effector of estrogen signaling in ERα-positive breast cancer

AU - Peterson, Esther A.

AU - Jenkins, Edmund C.

AU - Lofgren, Kristopher A.

AU - Chandiramani, Natasha

AU - Liu, Hui

AU - Aranda, Evelyn

AU - Barnett, Maryia

AU - Kenny, Paraic A.

PY - 2015/11/15

Y1 - 2015/11/15

N2 - Estrogen stimulation promotes epithelial cell proliferation in estrogen receptor (ERα)-positive breast cancer. Many ERα target genes have been enumerated, but the identities of the key effectors mediating the estrogen signal remain obscure. During mouse mammary gland development, the estrogen growth factor receptor (EGFR) ligand amphiregulin acts as an important stage-specific effector of estrogen signaling. In this study, we investigated the role of amphiregulin in breast cancer cell proliferation using human tissue samples and tumor xenografts in mice. Amphiregulin was enriched in ERα-positivehumanbreast tumor cells and required for estrogen-dependent growth of MCF7 tumor xenografts. Furthermore, amphiregulin levels were suppressed in patients treated with endocrine therapy. Suppression of EGF receptor signaling appeared necessary for the therapeutic response in this setting. Our findings implicate amphiregulin as a critical mediator of the estrogen response in ERα-positive breast cancer, emphasizing the importance of EGF receptor signaling in breast tumor pathogenesis and therapeutic response.

AB - Estrogen stimulation promotes epithelial cell proliferation in estrogen receptor (ERα)-positive breast cancer. Many ERα target genes have been enumerated, but the identities of the key effectors mediating the estrogen signal remain obscure. During mouse mammary gland development, the estrogen growth factor receptor (EGFR) ligand amphiregulin acts as an important stage-specific effector of estrogen signaling. In this study, we investigated the role of amphiregulin in breast cancer cell proliferation using human tissue samples and tumor xenografts in mice. Amphiregulin was enriched in ERα-positivehumanbreast tumor cells and required for estrogen-dependent growth of MCF7 tumor xenografts. Furthermore, amphiregulin levels were suppressed in patients treated with endocrine therapy. Suppression of EGF receptor signaling appeared necessary for the therapeutic response in this setting. Our findings implicate amphiregulin as a critical mediator of the estrogen response in ERα-positive breast cancer, emphasizing the importance of EGF receptor signaling in breast tumor pathogenesis and therapeutic response.

UR - http://www.scopus.com/inward/record.url?scp=84955089060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955089060&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-15-0709

DO - 10.1158/0008-5472.CAN-15-0709

M3 - Article

C2 - 26527289

AN - SCOPUS:84955089060

VL - 75

SP - 4830

EP - 4838

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 22

ER -